HRT Financial’s Denali Therapeutics DNLI Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2024
Q4 | – | Sell |
-16,943
| Closed | -$493K | – | 2362 |
|
2024
Q3 | $493K | Buy |
+16,943
| New | +$493K | ﹤0.01% | 1468 |
|
2024
Q1 | – | Sell |
-44,292
| Closed | -$950K | – | 2337 |
|
2023
Q4 | $950K | Buy |
44,292
+32,087
| +263% | +$688K | 0.01% | 940 |
|
2023
Q3 | $251K | Buy |
+12,205
| New | +$251K | ﹤0.01% | 1541 |
|
2022
Q4 | – | Sell |
-77,628
| Closed | -$2.38M | – | 2404 |
|
2022
Q3 | $2.38M | Buy |
77,628
+54,028
| +229% | +$1.66M | 0.03% | 523 |
|
2022
Q2 | $694K | Buy |
+23,600
| New | +$694K | 0.01% | 1228 |
|